Patient Group Directions

Applied filters

Patient Group Directions

Care Setting (14)
- Emergency medicine and urgent care (5)
- Occupational Health (6)
- Palliative and End of Life Care (1)
- Primary Care (2)
Events (2)
- Next Events (1)
- Past Events (1)
Guidance (152)
- Administering (11)
- Dosing (2)
- Governance (1)
- Medication Safety (1)
- Patient Group Directions (152)
- Policy, Commissioning and Managerial (8)
- Safety in Pregnancy (5)
- Service advice and planning (3)
- Supply (11)
- Unlicensed medicines (2)
Medicine (87)
- Aciclovir (2)
- Amoxicillin (1)
- Aspirin (1)
- Azithromycin (1)
- Benzylpenicillin (2)
- Ceftriaxone (1)
- Clarithromycin (5)
- Clotrimazole (2)
- Co-amoxiclav (1)
- Copper (1)
- Cytisinicline (1)
- Diamorphine (1)
- Diazepam (2)
- Doxycycline (4)
- Emtricitabine + Tenofovir alafenamide (1)
- Emtricitabine + Tenofovir disoproxil (1)
- Erythromycin (5)
- Estradiol + Dienogest (1)
- Estradiol + Nomegestrol (1)
- Ethinylestradiol + Desogestrel (1)
- Ethinylestradiol + Drospirenone (1)
- Ethinylestradiol + Etonogestrel (1)
- Ethinylestradiol + Gestodene (1)
- Ethinylestradiol + Levonorgestrel (1)
- Ethinylestradiol + Norelgestromin (1)
- Ethinylestradiol + Norethisterone (1)
- Ethinylestradiol + Norgestimate (1)
- Etonogestrel (2)
- Flucloxacillin (2)
- Fluconazole (1)
- Flumazenil (1)
- Fluticasone (1)
- Folic acid (1)
- Fusidic acid (1)
- Gadobutrol (1)
- Gadopiclenol (1)
- Gadoteric acid (1)
- Gadoteridol (1)
- Gadoxetic acid (1)
- Hydrogen peroxide (1)
- Hyoscine butylbromide (1)
- Imiquimod (1)
- Influenza vaccine (3)
- Iodixanol (1)
- Iohexol (1)
- Iomeprol (1)
- Iopamidol (1)
- Ioversol (1)
- Ketamine (1)
- Levonorgestrel (2)
- Lidocaine (5)
- Lidocaine + Prilocaine (1)
- Malathion (1)
- Medroxyprogesterone (2)
- Meglumine gadobenate (1)
- Metronidazole (2)
- Midazolam (2)
- Mifepristone (1)
- Misoprostol (1)
- Mometasone (1)
- Morphine (1)
- Nitrofurantoin (1)
- Permethrin (1)
- Phenoxymethylpenicillin (2)
- Podophyllotoxin (1)
- Prilocaine (1)
- Progesterone (1)
- Raltegravir (1)
- Sodium chloride (1)
- Tenofovir disoproxil + Emtricitabine (1)
- Terbutaline (1)
- Tramadol (1)
- Tranexamic acid (1)
- Trimethoprim (1)
- Ulipristal (1)
- Valaciclovir (1)
- Varenicline (1)
Publications (93)
- Explainer videos (3)
- Research and audits (3)
- Templates (87)
Specialty (79)
- Infection and infectious diseases (31)
- Neurological disorders (1)
- Obstetrics and gynaecology (1)
- Public Health (1)
- Radiology (13)
- Renal and urologic disorders (2)
- Reproductive health (14)
- Respiratory disorders (13)
- Sexual health (14)
- Skin disorders (14)
- Smoking cessation (2)
- Vaccinating (4)
Training and Development (5)

Buccal midazolam for seizures or symptomatic cocaine toxicity management

30 April 2026SPS PGD template for administering buccal midazolam for the management of seizures by registered Paramedics and Nurses.

Diazepam injection for seizures or symptomatic cocaine toxicity management

30 April 2026SPS PGD template for administering diazepam solution for injection for the management of seizures by registered Paramedics and Nurses.

Rectal diazepam for managing seizures

30 April 2026SPS PGD template for administering diazepam rectal tubes for the management of seizures by registered Paramedics and Nurses.

Tranexamic acid injection for treatment of severe haemorrhage

30 April 2026SPS PGD template for administering tranexamic acid injection for treatment of severe haemorrhage by registered Paramedics and Nurses.

PGDs, legal mechanisms and governance: what's new

9 June 2026An update session for those involved in medicines governance including managing PGDs and other legal mechanisms in practice.

Authorising Independent Healthcare Provider (IHP) PGDs

8 April 2026Considerations are needed when NHS or local authorities commission services using PGDs from independent healthcare providers.

Patient Group Directions in Complex Commissioning Scenarios

8 April 2026This guide supports planning and decision making and advises on governance processes when PGDs are used within commissioned services.

Patient Group Direction use in services provided by multiple organisations

8 April 2026Principles to be considered are outlined for Patient Group Directions used in the provision of medicines/vaccines in services provided by multiple organisations

Off-label or unlicensed product use under HMR 2012 exemptions

8 April 2026A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012

Managing Patient Group Directions following amendments or changes

8 April 2026There are requirements for all Patient Group Directions (PGDs) to be resigned or reauthorised after any amendment or change made during its valid to/from dates